October 28, 2025 | Doctored Truths, Havas Lynx, Havas Village Manchester, Health Misinformation
“Doctored Truths” exposes the escalating crisis of health misinformation and disinformation, which has been ranked the world’s top short-term risk to the world, for the second year in a row. Havas Lynx calls upon the pharmaceutical industry to leverage its unique position and vast clinical data to combat this growing threat to patient health and public trust.

The Doctored Truths white paper highlights a critical erosion of trust in medical expertise, with proprietary Point.1 data revealing declining confidence in healthcare professionals (HCPs) across generations and only half of patients trusting non-government organisations like the World Health Organisation. As patients increasingly turn to digital platforms for health guidance, nearly one-third of social media health content now contains misinformation, leaving individuals vulnerable to conspiracy theories, viral fads, and unqualified advice.
The tangible impact of this misinformation overload is stark:
This crisis is affecting every therapy area, undermining public health, social cohesion, and even economic stability, particularly impacting vulnerable groups where scientific understanding is limited or access to care is constrained.
“The spread of health misinformation isn’t just a concern; it’s a profound threat to patient well-being and the very foundation of evidence-based medicine,” says Claire Knapp, Chief Executive Officer at Havas Lynx. “Our ‘Doctored Truths’ white paper not only illuminates the scale of this problem but also underscores the immense responsibility and opportunity for the pharmaceutical industry. Pharma could hold the antidote – with its deep scientific expertise and extensive reach, it is uniquely positioned to reclaim trust and safeguard health outcomes. It’s not just an ethical imperative, but a strategic necessity for the industry’s future.”
The expectations for the pharmaceutical sector to act are clear. Point.1 data shows that 71% of HCPs believe pharma has a responsibility to tackle misinformation, yet only 41% feel enough is currently being done. Havas Lynx asserts that by stepping up to this challenge, pharma can not only shape its future reputation but also reinforce the very foundations of evidence-based healthcare.
Read the full “Doctored Truths” report and learn how your organisation can contribute to this vital initiative here.
This content was provided by Havas Lynx
Company Details
Latest Content from Havas Lynx
The Havas Lynx group are incredibly proud to launch ’Healthcare Heroes, the passion project.’ This campaign shares inspirational stories from doctors, nurses, patients, pioneers, and entrepreneurs, who are all dedicated…
Millennials are criticised as narcissistic, entitled and technology-obsessed, but our new campaign shows millennial healthcare professionals – mHCPs – in a different light. They have certainly grown up in a…
Seizing the opportunities in a new era of care
Making happier, healthier patients
Does pharma’s global model need a shake up?
Function over fashion
Applying science to the creative process to improve lives
Unlocking better outcomes in healthcare with UX
Unlocking better outcomes in healthcare with UX
Better for patients, better for business
